Amneal Pharmaceuticals (AMRX) to Move to Nasdaq
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Amneal Announces Move to Nasdaq
December 15, 2023 4:05 PM EST- Nasdaq move will be effective on December 27, 2023
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Amneal) (NYSE: AMRX) today announced that it will transfer its stock exchange listing to the Nasdaq Stock Market (Nasdaq) from the New York Stock Exchange (NYSE). The Company expects the Nasdaq listing to occur on December 27, 2023 and will continue to trade under the current symbol AMRX. Upon transferring, Amneal will become part of the Nasdaq Composite Index and Nasdaq Biotechnology Index.
We are pleased to join the community of global pharmaceutical companies listed on Nasdaq. We... More
